Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Does Jetblue Look Like a Value Play Here?: https://www.marketbeat.com/logos/articles/med_20231030194244_does-jetblue-look-like-a-value-play-here.jpg
Does Jetblue Look Like a Value Play Here?

What if you heard about a stock that provided you with nearly zero downside risk while potentially promising you an 80% upside? What is it? Here's a hint: it is one of the most beaten-down names

Should you buy Mattel and sell Hasbro stock? Here’s why: https://www.marketbeat.com/logos/articles/med_20231029140234_chart-mat4.jpg
Should you buy Mattel and sell Hasbro stock? Here’s why

The two largest iconic publicly traded toy companies released their Q3 2023 earnings reports. While the reports were starkly different, the reactions were similar in that they both saw their

CEPI und Moderna nutzen mRNA-Technologie zur Weiterentwicklung der „100 Days Mission“: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
CEPI und Moderna nutzen mRNA-Technologie zur Weiterentwicklung der „100 Days Mission“

Die neue Partnerschaft wird Modernas rasch reagierende und während der COVID-19-Pandemie klinisch validierte mRNA-Plattform zur rascheren Entwicklung von Impfstoffen gegen Epidemien und

CEPI and Moderna Harness mRNA Technology to Advance 100 Days Mission: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
CEPI and Moderna Harness mRNA Technology to Advance 100 Days Mission

New partnership will harness Moderna’s mRNA rapid-response platform, clinically validated during the COVID-19 pandemic, to accelerate epidemic and pandemic vaccine development

 

First project

Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot: https://www.marketbeat.com/logos/articles/med_20231019082941_why-these-3-equal-weighted-etfs-deserve-a-portfoli.jpg
Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot

In the investing world, not all exchange-traded funds (ETFs) are created equal. Quite literally, most aren’t. 

Most ETFs use a market capitalization weighting scheme to determine how much gets

Analysts Recommend These Stocks To Cushion The Automotive Slump: https://www.marketbeat.com/logos/articles/med_20231017072614_analysts-recommend-these-stocks-to-cushion-the-aut.jpg
Analysts Recommend These Stocks To Cushion The Automotive Slump

By now, most market participants are aware of the UAW (United Auto Workers) union strikes, which pose a significant risk to domestic auto manufacturers and their profitability. That is about as

Challenges Loom for Regional Banks as Interest Rates Surge: https://www.marketbeat.com/logos/articles/med_20231013074236_challenges-loom-for-regional-banks-as-interest-rat.jpg
Challenges Loom for Regional Banks as Interest Rates Surge

As the big banks begin reporting earnings, will investors get some insights into whether higher interest rates will mean pressure on profits.

First up are JPMorgan Chase & Co. (NYSE: JPM), Wells

Challenges Loom for Regional Banks as Interest Rates Surge: https://www.marketbeat.com/logos/articles/med_20231013074236_challenges-loom-for-regional-banks-as-interest-rat.jpg
Challenges Loom for Regional Banks as Interest Rates Surge

As the big banks begin reporting earnings, will investors get some insights into whether higher interest rates will mean pressure on profits.

First up are JPMorgan Chase & Co. (NYSE: JPM), Wells

MongoDB Is Well-Positioned For Growth as AI Use Increases: https://www.marketbeat.com/logos/articles/med_20231013075520_mongodb-is-well-positioned-for-growth-as-ai-use-in.jpg
MongoDB Is Well-Positioned For Growth as AI Use Increases

Database specialist MongoDB Inc. (NASDAQ: MDB) has been forming a double-bottom base with a buy point above $414. Within its industry, the stock’s price performance is about equal with Splunk Inc.

5 Reasons Gilead Sciences is a Better Buy Than You Think: https://www.marketbeat.com/logos/articles/med_20231010085432_chart-gild-10102023ver001.png
5 Reasons Gilead Sciences is a Better Buy Than You Think

Shares of Gilead Sciences (NASDAQ: GILD) are down roughly 20% from their highs in 2023 and, like other stocks in correction this year, are showing signs of a bottom. The price pressure in 2023 is

Jobs Are Going To The Construction Industry, Momentum Play Time: https://www.marketbeat.com/logos/articles/med_20231010075509_jobs-are-going-to-the-construction-industry-moment.jpg
Jobs Are Going To The Construction Industry, Momentum Play Time

When an industry decides to go on a hiring spree, you better bet on the respective firms' overall management to expect a surge of demand - and, therefore, profits - coming right around the corner

Time to Clean Up with These 3 Profitable Garbage Stocks: https://www.marketbeat.com/logos/articles/med_20231005081250_time-to-clean-up-with-these-3-profitable-garbage-s.jpg
Time to Clean Up with These 3 Profitable Garbage Stocks

If there's one thing that will continue to compound and swell for as long as there are cities, communities and towns, it’s garbage. Trash, waste, junk, litter, rubbish, muck, and refuse colorfully

5 of the Most Active Penny Stocks Worth Your Precious Time: https://www.marketbeat.com/logos/articles/med_20231004092552_chart-chpt-1042023ver001.png
5 of the Most Active Penny Stocks Worth Your Precious Time

Penny stocks can be a treasure trove of investment opportunities, and the list of Most Active Penny Stocks is a good place to start looking. The downside is that many penny stocks are active for

Tip The Risk / Reward Scale In your Favor With These 3 Names: https://www.marketbeat.com/logos/articles/med_20231004082435_tip-the-risk-reward-scale-in-your-favor-with-these.jpg
Tip The Risk / Reward Scale In your Favor With These 3 Names

Widely watched inflation indicators have proved to be more persistent than initially thought, making the argument from the FED chairman, Jerome Powell, a shrug from the past year. Inflation has

3 Stocks For the Resurgent Energy Rally: https://www.marketbeat.com/logos/articles/med_20231004081930_3-stocks-for-the-resurgent-energy-rally.jpg
3 Stocks For the Resurgent Energy Rally

The oil and gas machinery and equipment industry has been rising up the ranks this year in terms of aggregate price. 

While two very small stocks, Geospace Technologies Corp. (NASDAQ: GEOS) and

Are the S&P 500's Biggest Q3 Losers Next Year's Winners?: https://www.marketbeat.com/logos/articles/med_20231004081025_are-the-sp-500s-biggest-q3-losers-next-years-winne.jpg
Are the S&P 500's Biggest Q3 Losers Next Year's Winners?

What started out to be a promising third quarter for U.S. stocks turned into a dud. On the backs of artificial intelligence (AI) excitement, the S&P 500 stormed out of the gates in July only to

Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?: https://www.marketbeat.com/logos/articles/med_20230925063400_is-jet-blues-descent-into-penny-stock-territory-an.jpg
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?

JetBlue Airways Corporation (NASDAQ: JBLU) stock is selling for peanuts.

On Friday, shares of the low-fare airline fell to their lowest level since 2012. Trading below $5.00, Jet’s Blue’s second

Etsy Gets an Upgrade and $100 Target...Is the Bottom Finally In?: https://www.marketbeat.com/logos/articles/med_20230920075430_etsy-gets-an-upgrade-and-100-target.jpg
Etsy Gets an Upgrade and $100 Target...Is the Bottom Finally In?

When Etsy, Inc. (NASDAQ:ETSY) shares dipped to a three-year low last week, Wolfe Research decided it was time for an upgrade. 

On September 12th, the sell-side research firm bumped its rating on

3 Reasons Wall Street Is 100% Bullish on This Recent IPO: https://www.marketbeat.com/logos/articles/med_20230920055846_3-reasons-wall-street-is-100-bullish-on-this-recen.jpg
3 Reasons Wall Street Is 100% Bullish on This Recent IPO

Known for keeping money in consumer pockets, Savers Value Village, Inc. (NYSE: SVV) may soon be putting money in investor accounts.

North America’s biggest for-profit thrift store operator

Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?: https://www.marketbeat.com/logos/articles/med_20230917134923_chart-lly3.jpg
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?

Pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) stock has been on a tear, trading up 57.7% year-to-date (YTD). The company is firing on all cylinders with its leading medications and a highly

2 Wrecked Stocks Keeping Cars on the Road Ready for Repair: https://www.marketbeat.com/logos/articles/med_20230910180255_chart-gt-3.jpg
2 Wrecked Stocks Keeping Cars on the Road Ready for Repair

Rising oil prices and the cooling vehicle market have one thing in common: cars. Both developments impact vehicle sales and usage. Vehicle maintenance, service and repair companies keep cars on

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union

The positive opinion follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines for autumn/winter 2023 vaccination campaigns

 

Der Ausschuss für Humanarzneimittel der EMA gibt positives Gutachten heraus, in dem die Zulassung des aktualisierten COVID-19-Impfstoffs von Moderna in der Europäischen Union empfohlen wird: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
Der Ausschuss für Humanarzneimittel der EMA gibt positives Gutachten heraus, in dem die Zulassung des aktualisierten COVID-19-Impfstoffs von Moderna in der Europäischen Union empfohlen wird

Die positive Stellungnahme folgt der Empfehlung von Regulierungsbehörden und globalen Gesundheitsbehörden, monovalente XBB.1.5-COVID-19-Impfstoffe für Impfkampagnen im Herbst/Winter 2023 zu

America's Favorite Dividend Is On Sale, Grab Realty Income Now: https://www.marketbeat.com/logos/articles/med_20230913073705_americas-favorite-dividend-is-on-sale-grab-realty.jpg
America's Favorite Dividend Is On Sale, Grab Realty Income Now

The real estate market in the United States is undergoing a tantrum, as neither builders nor would-be buyers are happy with how mortgage rates are behaving today. Shares of Realty Income (NYSE: O)

2 Value Stocks To Claim Your Place In The Appliances Bottom: https://www.marketbeat.com/logos/articles/med_20230911065518_2-value-stocks-to-claim-your-place-in-the-applianc.jpg
2 Value Stocks To Claim Your Place In The Appliances Bottom

Today's economic uncertainty, namely wild guesses from economists and talking heads as to where the United States economy will head next, sends aftershocks across different industries and makes